| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABMD | Common Stock $.01 par value | Options Exercise | $579K | +25K | +11.81% | $23.15 | 237K | Aug 5, 2021 | Direct | F5 |
| transaction | ABMD | Common Stock $.01 par value | Sale | -$5.07M | -14.9K | -6.29% | $340.27 | 222K | Aug 5, 2021 | Direct | F6, F7 |
| transaction | ABMD | Common Stock $.01 par value | Sale | -$1.84M | -5.38K | -2.43% | $341.44 | 216K | Aug 5, 2021 | Direct | F6, F8 |
| transaction | ABMD | Common Stock $.01 par value | Sale | -$457K | -1.34K | -0.62% | $342.48 | 215K | Aug 5, 2021 | Direct | F6, F9 |
| transaction | ABMD | Common Stock $.01 par value | Sale | -$515K | -1.5K | -0.7% | $343.32 | 214K | Aug 5, 2021 | Direct | F6, F10 |
| transaction | ABMD | Common Stock $.01 par value | Sale | -$173K | -500 | -0.23% | $345.33 | 213K | Aug 5, 2021 | Direct | F6, F11 |
| transaction | ABMD | Common Stock $.01 par value | Sale | -$138K | -400 | -0.19% | $346.08 | 213K | Aug 5, 2021 | Direct | F6, F12 |
| transaction | ABMD | Common Stock $.01 par value | Sale | -$344K | -1K | -0.47% | $344.43 | 212K | Aug 5, 2021 | Direct | F6, F13 |
| holding | ABMD | Common Stock $.01 par value | 52.6K | Aug 5, 2021 | By Trust - A | ||||||
| holding | ABMD | Common Stock $.01 par value | 73.7K | Aug 5, 2021 | By Trust - B | ||||||
| holding | ABMD | Common Stock $.01 par value | 32.8K | Aug 5, 2021 | By Trust - C | ||||||
| holding | ABMD | Common Stock $.01 par value | 655 | Aug 5, 2021 | By Trust - D | ||||||
| holding | ABMD | Common Stock $.01 par value | 38.6K | Aug 5, 2021 | By Trust - E | ||||||
| holding | ABMD | Common Stock $.01 par value | 85K | Aug 5, 2021 | By Trust - F |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABMD | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -25K | -41.67% | $0.00 | 35K | Aug 5, 2021 | Common stock | 25K | $23.15 | Direct | F1, F2, F5 |
| holding | ABMD | Stock Option (right to buy) | 85K | Aug 5, 2021 | Common Stock | 0 | $21.55 | Direct | F2, F3 | |||||
| holding | ABMD | Stock Option (right to buy) | 35K | Aug 5, 2021 | Common Stock | 0 | $66.25 | Direct | F2, F3 | |||||
| holding | ABMD | Stock Option (right to buy) | 30.5K | Aug 5, 2021 | Common Stock | 0 | $99.62 | Direct | F3, F4 | |||||
| holding | ABMD | Stock Option (right to buy) | 33K | Aug 5, 2021 | Common Stock | 0 | $134.51 | Direct | F3, F4 | |||||
| holding | ABMD | Stock Option (right to buy) | 30K | Aug 5, 2021 | Common Stock | 0 | $381.97 | Direct | F3, F4 | |||||
| holding | ABMD | Stock Option (right to buy) | 50K | Aug 5, 2021 | Common Stock | 0 | $266.39 | Direct | F3, F4 | |||||
| holding | ABMD | Stock Option (Right to Buy) | 20.9K | Aug 5, 2021 | Common Stock | 0 | $223.90 | Direct | F3, F4 | |||||
| holding | ABMD | Stock Option (Right to Buy) | 30K | Aug 5, 2021 | Common Stock | 0 | $283.88 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6. |
| F2 | Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. |
| F3 | These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6. |
| F4 | Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan. |
| F5 | Exercise of stock options pursuant to reporting owners 10b5-1 plan. |
| F6 | Sale of common stock pursuant to reporting owner's 10b5-1 plan. |
| F7 | This price represents the sale price of the transactions on the reported date at $340.2661. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. |
| F8 | This price represents the sale price of the transactions on the reported date at $341.4448. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. |
| F9 | This price represents the sale price of the transactions on the reported date at $342.4849. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. |
| F10 | This price represents the sale price of the transactions on the reported date at $3343.3223. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. |
| F11 | This price represents the sale price of the transactions on the reported date at $345.3314. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. |
| F12 | This price represents the sale price of the transactions on the reported date at $346.0750. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. |
| F13 | This price represents the sale price of the transactions on the reported date at $344.4270. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. |